90.43
price down icon1.36%   -1.22
 
loading
Schlusskurs vom Vortag:
$91.65
Offen:
$91.48
24-Stunden-Volumen:
391.90K
Relative Volume:
0.38
Marktkapitalisierung:
$45.33B
Einnahmen:
$9.76B
Nettoeinkommen (Verlust:
$1.16B
KGV:
38.65
EPS:
2.34
Netto-Cashflow:
$665.00M
1W Leistung:
-0.76%
1M Leistung:
+7.12%
6M Leistung:
-0.84%
1J Leistung:
+17.62%
1-Tages-Spanne:
Value
$90.34
$91.57
1-Wochen-Bereich:
Value
$90.09
$93.57
52-Wochen-Spanne:
Value
$74.53
$101.10

Alcon Inc Stock (ALC) Company Profile

Name
Firmenname
Alcon Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
25,315
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
ALC's Discussions on Twitter

Vergleichen Sie ALC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
ALC
Alcon Inc
90.39 45.33B 9.76B 1.16B 665.00M 2.34
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
586.99 209.89B 8.35B 2.32B 1.30B 6.41
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
228.04 68.23B 20.18B 1.71B 3.07B 5.94
Medical Instruments & Supplies icon
RMD
Resmed Inc
236.44 34.84B 4.93B 1.25B 1.38B 8.47
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
324.74 23.97B 2.88B 499.60M 321.60M 6.74

Alcon Inc Stock (ALC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-24 Bestätigt Needham Buy
2025-01-10 Hochstufung Redburn Atlantic Neutral → Buy
2024-12-17 Bestätigt Needham Buy
2024-11-12 Bestätigt Needham Buy
2024-10-10 Hochstufung Redburn Atlantic Sell → Neutral
2024-09-10 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2024-07-15 Hochstufung Morgan Stanley Underweight → Equal-Weight
2024-05-15 Hochstufung Oppenheimer Perform → Outperform
2024-04-10 Eingeleitet Goldman Buy
2024-03-14 Eingeleitet RBC Capital Mkts Sector Perform
2024-02-06 Fortgesetzt KeyBanc Capital Markets Overweight
2024-01-23 Eingeleitet Bernstein Outperform
2023-12-18 Herabstufung Redburn Atlantic Neutral → Sell
2023-12-12 Eingeleitet Stifel Buy
2023-12-04 Herabstufung Morgan Stanley Equal-Weight → Underweight
2023-08-17 Hochstufung JP Morgan Neutral → Overweight
2023-05-30 Fortgesetzt Morgan Stanley Equal-Weight
2023-05-10 Hochstufung Robert W. Baird Neutral → Outperform
2023-03-01 Hochstufung Societe Generale Sell → Hold
2022-12-22 Eingeleitet Mizuho Buy
2022-11-17 Herabstufung Societe Generale Hold → Sell
2022-08-11 Herabstufung Societe Generale Buy → Hold
2022-05-13 Fortgesetzt Credit Suisse Outperform
2022-05-12 Hochstufung Stephens Equal-Weight → Overweight
2022-04-08 Eingeleitet Needham Buy
2022-03-11 Eingeleitet BofA Securities Buy
2022-01-18 Herabstufung Stephens Overweight → Equal-Weight
2022-01-07 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-10-01 Eingeleitet Oppenheimer Perform
2021-07-14 Eingeleitet Deutsche Bank Buy
2021-05-06 Hochstufung Citigroup Sell → Neutral
2021-03-22 Hochstufung BTIG Research Neutral → Buy
2020-11-12 Herabstufung Guggenheim Buy → Neutral
2020-07-06 Herabstufung Citigroup Neutral → Sell
2020-07-06 Eingeleitet KeyBanc Capital Markets Sector Weight
2020-06-16 Hochstufung Guggenheim Neutral → Buy
2020-04-08 Herabstufung Robert W. Baird Outperform → Neutral
2020-03-26 Hochstufung Argus Hold → Buy
2020-03-24 Hochstufung Societe Generale Sell → Hold
2020-03-13 Hochstufung UBS Neutral → Buy
2020-03-05 Eingeleitet Citigroup Neutral
2020-02-26 Hochstufung Berenberg Hold → Buy
2020-01-08 Eingeleitet Argus Hold
2019-10-29 Eingeleitet Stephens Equal-Weight
2019-08-21 Bestätigt BofA/Merrill Neutral
2019-06-24 Eingeleitet SVB Leerink Mkt Perform
2019-06-14 Eingeleitet BTIG Research Neutral
2019-05-10 Eingeleitet Robert W. Baird Outperform
2019-05-02 Eingeleitet Credit Suisse Outperform
Alle ansehen

Alcon Inc Aktie (ALC) Neueste Nachrichten

pulisher
Feb 04, 2025

Alcon: An Eyecare Leader With Strong Profit Margins, But Overheated Valuation - Seeking Alpha

Feb 04, 2025
pulisher
Jan 31, 2025

Alcon Laboratories is considering a major $100M expansion of its Fort Worth campus - AOL

Jan 31, 2025
pulisher
Jan 28, 2025

Alcon Loses Bid to Veto Aurion IPO, Can Still Oppose Listing (1) - Bloomberg Law

Jan 28, 2025
pulisher
Jan 28, 2025

Intraocular Lens Market Forecast and Company Analysis Report 2025-2033 Featuring Alcon, Bausch Health, Hoya, Johnson & Johnson, STAAR Surgical Co, Carl Zeiss Meditec, and Novartis - GlobeNewswire

Jan 28, 2025
pulisher
Jan 27, 2025

Alcon stock price target cut to $106 by Needham, maintains Buy - MSN

Jan 27, 2025
pulisher
Jan 27, 2025

Alcon Breaks Above 200-Day Moving AverageBullish for ALC - Nasdaq

Jan 27, 2025
pulisher
Jan 27, 2025

Artificial Tears Market Overall Study Report 2025-2032 | - openPR

Jan 27, 2025
pulisher
Jan 24, 2025

Alcon stock price target cut to $105 by KeyBanc - MSN

Jan 24, 2025
pulisher
Jan 24, 2025

Apple To $253? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

Jan 24, 2025
pulisher
Jan 23, 2025

Do Options Traders Know Something About Alcon (ALC) Stock We Don't? - Yahoo Finance

Jan 23, 2025
pulisher
Jan 22, 2025

First Week of March 21st Options Trading For Alcon (ALC) - Nasdaq

Jan 22, 2025
pulisher
Jan 21, 2025

Alcon Inc (ALC) Shares Up 3.7% on Jan 21 - GuruFocus.com

Jan 21, 2025
pulisher
Jan 17, 2025

Modernizing a Legacy Application on AWS Serverless with Alcon - AWS Blog

Jan 17, 2025
pulisher
Jan 17, 2025

Modernizing a Legacy Application on AWS Serverless with Alcon | Case Study | AWS - AWS Blog

Jan 17, 2025
pulisher
Jan 15, 2025

Alcon to Seek M&A -January 14, 2025 at 07:30 pm EST - Marketscreener.com

Jan 15, 2025
pulisher
Jan 13, 2025

Should Weakness in Alcon Inc.'s (VTX:ALC) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - Yahoo Finance

Jan 13, 2025
pulisher
Jan 13, 2025

Ophthalmic Drugs Global Market Report 2025: Innovations in Retinal Disorders, Glaucoma Drive Global Ophthalmic Medicines Surge - GlobeNewswire Inc.

Jan 13, 2025
pulisher
Jan 13, 2025

Redburn raises Alcon stock rating to Buy By Investing.com - Investing.com Australia

Jan 13, 2025
pulisher
Jan 12, 2025

Redburn raises Alcon stock rating to Buy - Investing.com

Jan 12, 2025
pulisher
Jan 10, 2025

Dry Eye Disease Market Is Booming Worldwide 2025-2032 | Novartis - openPR

Jan 10, 2025
pulisher
Jan 09, 2025

Contact Lens Market Deep Research Report with Forecast by 2031 | Bausch & Lomb Incorporated, Alcon Vision LLC - EIN News

Jan 09, 2025
pulisher
Jan 08, 2025

Alcon Inc. (VTX:ALC) is favoured by institutional owners who hold 63% of the company - Simply Wall St

Jan 08, 2025
pulisher
Jan 02, 2025

Seeing Brilliance in APAC: Alcon’s Vision Care Innovations and Eye Health Mission - BSA bureau

Jan 02, 2025
pulisher
Dec 31, 2024

Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference - Marketscreener.com

Dec 31, 2024
pulisher
Dec 31, 2024

Alcon Laboratories issues recall for Systane eye drops due to fungal contamination - Top Class Actions

Dec 31, 2024
pulisher
Dec 27, 2024

News Release – DOH Issues Recall Alert For Alcon Laboratories Systane Brand Lubricant Eye Drops Due to Fungal - EIN News

Dec 27, 2024
pulisher
Dec 26, 2024

DOH issues recall alert for Alcon Laboratories Systane Brand Lubricant Eye Drops - Maui Now

Dec 26, 2024
pulisher
Dec 26, 2024

Alcon Labs recalling eye drops - Valley News

Dec 26, 2024
pulisher
Dec 26, 2024

Alcon Laboratories Recalls Systane Eye Drops Nationwide Over Fungal Contamination Risk - Black Enterprise

Dec 26, 2024
pulisher
Dec 26, 2024

Alcon's (VTX:ALC) investors will be pleased with their respectable 41% return over the last five years - Simply Wall St

Dec 26, 2024
pulisher
Dec 25, 2024

Alcon recalls Systane eye drops due to potential fungal contamination risk - WRAL News

Dec 25, 2024
pulisher
Dec 24, 2024

Alcon Laboratories Recalls Systane Eye Drops Over Fungal Risk - Franklin County Free Press

Dec 24, 2024
pulisher
Dec 24, 2024

Alcon Labs Recalls Systane Lubricant Eye Drops Over Fungal Contamination - Nasdaq

Dec 24, 2024
pulisher
Dec 24, 2024

Refractive Surgery Market Growth in Future Scope 2024-2031 | - openPR

Dec 24, 2024
pulisher
Dec 24, 2024

Retinal Laser Photocoagulation Market Top PlayersAlcon, A.R.C Laser, Ellex Medical, Carl Zeiss, Quantel Medical. - openPR

Dec 24, 2024
pulisher
Dec 23, 2024

Here's Why Alcon (ALC) is a Strong Growth Stock - MSN

Dec 23, 2024
pulisher
Dec 23, 2024

Aesthetic Ophthalmology Devices Business Analysis Report 2024-2030 Featuring 40+ Key Players Including Abbott, Bausch & Lomb, Alcon, Allergan, Carl Zeiss, Haag Streit, Meditec, Topcon, Zeimer - GlobeNewswire

Dec 23, 2024
pulisher
Dec 21, 2024

Alcon Laboratories Issues Voluntary Nationwide Recall of One (1) Lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count (Lot 10101), Due to Fungal Contamination - US Recall News

Dec 21, 2024
pulisher
Dec 19, 2024

Alcon a top pick for 2025 at Needham on upcoming product launches - MSN

Dec 19, 2024
pulisher
Dec 18, 2024

Alcon Top Pick for 2025 at Needham, added to Conviction List - MSN

Dec 18, 2024

Finanzdaten der Alcon Inc-Aktie (ALC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_instruments_supplies RMD
$236.41
price down icon 0.18%
medical_instruments_supplies WST
$325.43
price down icon 1.38%
medical_instruments_supplies BDX
$228.18
price up icon 0.50%
medical_instruments_supplies COO
$94.00
price down icon 1.33%
$215.13
price down icon 1.76%
Kapitalisierung:     |  Volumen (24h):